Active Funding Opportunities and Notices for NICHD

NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.

NOTs and Active NOFOs for NICHD

Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.

Number Exp. Date Activity Code(s) Title
NOT-OD-22-124 November 13, 2024 K99/R00,K23,K08,K01,K43,UE5 Notice of Special Interest (NOSI): Mentored Career Development Awards to Foster the Careers of Investigators Pursuing Research Related to Down syndrome as Part of the INCLUDE Project
RFA-NS-22-041 September 22, 2024 U01 BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Basic Experimental Studies with Humans Required)
NOT-HD-22-014 January 1, 2027 Notice of NICHD Participation in PAR-22-138, Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)"
NOT-TW-22-001 January 1, 2027 Promoting Equity in Global Health Research
NOT-HD-22-023 January 1, 2027 Notice of Pre-Application Webinars for the Maternal-Fetal Medicine Units Network and Neonatal Research Network Funding Opportunity Announcements
NOT-OD-22-107 May 8, 2025 333,R01,R34,R21,R61/R33,U01,UG3/UH3 Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening
NOT-OD-22-106 May 8, 2025 R03,R01,R34,R21,UG3/UH3,R61/R33,333 Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan
NOT-HD-22-007 January 1, 2027 Notice of Change to PAR-20-101 "Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed)"
PAR-22-109 May 8, 2025 R21 Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
PAR-22-105 May 8, 2025 R01 Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
NOT-HD-22-019 January 1, 2027 Notice of NICHD Participation in NOT-CA-22-037, Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research"
NOT-HD-22-020 January 1, 2027 Notice of NICHD Participation in PAR-22-116, International Bioethics Research Training Program (D43 Clinical Trial Optional)"
PAR-22-106 September 8, 2025 R03 Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
PAR-22-167 October 18, 2024 UG3/UH3 Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
NOT-HD-22-021 January 1, 2027 Notice of NICHD Participation in PAR-22-118, International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)"
NOT-HD-22-018 January 1, 2027 Notice of Intent to Publish a Funding Opportunity Announcement for Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network Clinical Research Centers
NOT-HD-22-008 January 1, 2027 Request for Information: Call for Nominations for NICHD's Best Pharmaceuticals for Children Act Priorities in Pediatric Therapeutics 2022-2023
NOT-HD-22-013 January 1, 2027 Notice of Intent to Publish a Funding Opportunity Announcement for Maternal and Pediatric Precision in Therapeutics (MPRINT) Translational Research Resource Platform (TRRP) (U24 Clinical Trial Not Allowed)
NOT-HD-22-003 June 6, 2024 333 Notice of Special Interest (NOSI) - Administrative Supplements for Research of Emerging and Existing Issues of COVID-19 Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities
RFA-OD-22-008 July 2, 2024 R03 Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed)
top of pageBACK TO TOP